Setting

Asia Pacific Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Published: 30 Nov 2021 | Report Code: 10248281 | Pages: 139

Asia Pacific enteral nutrition market will grow by 10.3% annually with a total addressable market cap of $44.18 billion over 2021-2030 owing to the increasing incidence of malnutrition, rising number of patients suffering with chronic diseases, and surge in adoption of enteral nutrition over parenteral nutrition due to lower cost and complications of enteral nutrition. Highlighted with 70 tables and 56 figures, this 139-page report “Asia Pacific Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19). In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country. Based on Nutrient, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Protein Based Nutrition o Standard Protein Diet o High Protein Supplement o Protein for Diabetic Patients o Other Protein-based Nutitions • Carbohydrates Based Nutrition • Fat Based Nutrition • Vitamin Based Nutrition • Other Nutrition Types Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Critical Care • Diabetes • Neurology • Oncology • Other Applications Based on Category, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Enteral Nutrition for Chronic Illness • Enteral Nutrition with Standard Formula Based on Product Form, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Liquid Enteral Nutrition • Powder Enteral Nutrition Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Pediatric • Adults • Geriatric Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Distribution by Hospitals • Distribution by Retail Pharmacies • Distribution by Online Pharmacies Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Nutrient, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories B. Braun Melsungen AG Baxter International, Inc. Danone S.A. Fresenius Kabi AG Asia Pacific Health Products, Inc. Hormel Foods Corporation Meiji Holdings Co., Ltd. Nestle S.A. Reckitt Benckiser (Mead Johnson & Company LLC) Victus, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) 

Table Of Contents:
1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	15
1.2.6 Market Size/Share Estimation	16
1.2.7 Research Limitations	17
1.3 Executive Summary	18
2 Market Overview and Dynamics	21
2.1 Market Size and Forecast	21
2.1.1 Impact of COVID-19 on World Economy	22
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	29
2.4 Emerging Opportunities and Market Trends	32
2.5 Porter’s Fiver Forces Analysis	36
3 Segmentation of Asia Pacific Market by Nutrient	40
3.1 Market Overview by Nutrient	40
3.2 Protein Based Nutrition	42
3.2.1 Standard Protein Diet	44
3.2.2 High Protein Supplement	45
3.2.3 Protein for Diabetic Patients	46
3.2.4 Other Protein-based Nutitions	47
3.3 Carbohydrates Based Nutrition	48
3.4 Fat Based Nutrition	49
3.5 Vitamin Based Nutrition	50
3.6 Other Nutrition Types	51
4 Segmentation of Asia Pacific Market by Application	52
4.1 Market Overview by Application	52
4.2 Critical Care	54
4.3 Diabetes	55
4.4 Neurology	56
4.5 Oncology	57
4.6 Other Applications	58
5 Segmentation of Asia Pacific Market by Category	59
5.1 Market Overview by Category	59
5.2 Enteral Nutrition for Chronic Illness	61
5.3 Enteral Nutrition with Standard Formula	62
6 Segmentation of Asia Pacific Market by Product Form	63
6.1 Market Overview by Product Form	63
6.2 Liquid Enteral Nutrition	65
6.3 Powder Enteral Nutrition	66
7 Segmentation of Asia Pacific Market by End User	67
7.1 Market Overview by End User	67
7.2 Pediatric	69
7.3 Adults	70
7.4 Geriatric	71
8 Segmentation of Asia Pacific Market by Distribution Channel	72
8.1 Market Overview by Distribution Channel	72
8.2 Distribution by Hospitals	74
8.3 Distribution by Retail Pharmacies	75
8.4 Distribution by Online Pharmacies	76
9 Asia-Pacific Market 2019-2030 by Country	77
9.1 Overview of Asia-Pacific Market	77
9.2 Japan	80
9.3 China	84
9.4 Australia	87
9.5 India	89
9.6 South Korea	92
9.7 Rest of APAC Region	95
10 Competitive Landscape	97
10.1 Overview of Key Vendors	97
10.2 New Product Launch, Partnership, Investment, and M&A	100
10.3 Company Profiles	101
Abbott Laboratories	101
B. Braun Melsungen AG	103
Baxter International, Inc.	107
Danone S.A.	110
Fresenius Kabi AG	113
Global Health Products, Inc.	117
Hormel Foods Corporation	119
Meiji Holdings Co., Ltd.	121
Nestle S.A.	123
Reckitt Benckiser (Mead Johnson & Company LLC)	128
Victus, Inc.	131
11 Investing in Asia Pacific Market: Risk Assessment and Management	133
11.1 Risk Evaluation of Asia Pacific Market	133
11.2 Critical Success Factors (CSFs)	136
Related Reports and Products	139
List Of Tables:

Table 1.  Snapshot of Asia Pacific Enteral Nutrition Market, 2020-2030	19
Table 2. Growth Rate of World GDP, 2020-2022	23
Table 3.  Main Product Trends and Market Opportunities in Asia Pacific Enteral Nutrition Market	32
Table 4. Asia Pacific Enteral Nutrition Market by Nutrient, 2019-2030, $ mn	40
Table 5. Asia Pacific Enteral Nutrition Market: Protein Based Nutrition by Type, 2019-2030, $ mn	43
Table 6. Asia Pacific Enteral Nutrition Market by Application, 2019-2030, $ mn	52
Table 7. Asia Pacific Enteral Nutrition Market by Category, 2019-2030, $ mn	59
Table 8. Asia Pacific Enteral Nutrition Market by Product Form, 2019-2030, $ mn	63
Table 9. Asia Pacific Enteral Nutrition Market by End User, 2019-2030, $ mn	67
Table 10. Asia Pacific Enteral Nutrition Market by Distribution Channel, 2019-2030, $ mn	72
Table 11. APAC Enteral Nutrition Market by Country, 2019-2030, $ mn	78
Table 12. Japan Enteral Nutrition Market by Nutrient, 2019-2030, $ mn	82
Table 13. Japan Enteral Nutrition Market by Application, 2019-2030, $ mn	82
Table 14. Japan Enteral Nutrition Market by End User, 2019-2030, $ mn	82
Table 15. Dealers of Enteral Nutrition in Japan	83
Table 16. China Enteral Nutrition Market by Nutrient, 2019-2030, $ mn	85
Table 17. China Enteral Nutrition Market by Application, 2019-2030, $ mn	85
Table 18. China Enteral Nutrition Market by End User, 2019-2030, $ mn	85
Table 19. Dealers of Enteral Nutrition in China	86
Table 20. Australia Enteral Nutrition Market by Nutrient, 2019-2030, $ mn	88
Table 21. Australia Enteral Nutrition Market by Application, 2019-2030, $ mn	88
Table 22. Australia Enteral Nutrition Market by End User, 2019-2030, $ mn	88
Table 23. India Enteral Nutrition Market by Nutrient, 2019-2030, $ mn	90
Table 24. India Enteral Nutrition Market by Application, 2019-2030, $ mn	90
Table 25. India Enteral Nutrition Market by End User, 2019-2030, $ mn	90
Table 26. Dealers of Enteral Nutrition in India	91
Table 27. South Korea Enteral Nutrition Market by Nutrient, 2019-2030, $ mn	93
Table 28. South Korea Enteral Nutrition Market by Application, 2019-2030, $ mn	93
Table 29. South Korea Enteral Nutrition Market by End User, 2019-2030, $ mn	93
Table 30. Dealers of Enteral Nutrition in South Korea	94
Table 31. Enteral Nutrition Market in Rest of APAC by Country, 2019-2030, $ mn	96
Table 32. Abbott Laboratories: Company Snapshot	101
Table 33. Abbott Laboratories: Business Segmentation	101
Table 34. Abbott Laboratories: Product Portfolio	102
Table 35. Abbott Laboratories: Revenue, 2016-2018, $ mn	102
Table 36. B Braun Melsungen Ag: Company Snapshot	103
Table 37. B Braun Melsungen Ag: Business Segmentation	104
Table 38. B Braun Melsungen Ag: Revenue by Region	104
Table 39. B Braun Melsungen Ag: Product Portfolio	105
Table 40. Baxter International Inc.: Company Snapshot	107
Table 41. Baxter International Inc.: Business Segmentation	107
Table 42. Baxter International Inc.: Revenue by Region	108
Table 43. Baxter International Inc.: Product Portfolio	108
Table 44. Danone SA: Company Snapshot	110
Table 45. Danone SA: Breakdown of Revenue by Region, 2017	111
Table 46. Danone SA: Business Segmentation	111
Table 47. Danone SA: Product Portfolio	111
Table 48. Fresenius Kabi Ag: Company Snapshot	113
Table 49. Fresenius Kabi Ag: Business Segmentation	114
Table 50. Fresenius Kabi Ag: Revenue by Region	114
Table 51. Fresenius Kabi Ag: Product Portfolio	114
Table 52. Global Health Products, Inc.: Company Snapshot	117
Table 53. Global Health Products, Inc.: Product Portfolio	118
Table 54. Hormel Foods Corporation: Company Snapshot	119
Table 55. Hormel Foods Corporation: Product Portfolio	120
Table 56. Meiji Holdings Co., Ltd.: Company Snapshot	121
Table 57. Meiji Holdings Co., Ltd.: Business Segmentation	122
Table 58. Meiji Holdings Co., Ltd.: Product Portfolio	122
Table 59. Nestlé S.A.: Company Snapshot	123
Table 60. Nestlé S.A.: Business Segmentation	123
Table 61. Nestlé S.A.: Product Portfolio	124
Table 62. Nestlé S.A.: Revenue, 2018-2020, $ bn	126
Table 63. Reckitt Benckiser: Company Snapshot	128
Table 64. Reckitt Benckiser: Business Segmentation	129
Table 65. Reckitt Benckiser: Product Portfolio	129
Table 66. Victus, Inc.: Company Snapshot	131
Table 67. Victus, Inc.: Business Segmentation	132
Table 68. Victus, Inc.: Product Portfolio	132
Table 69.  Risk Evaluation for Investing in Asia Pacific Market, 2020-2030	134
Table 70. Critical Success Factors and Key Takeaways	137
List Of Figures:

Figure 1. Research Method Flow Chart	12
Figure 2. Breakdown of Primary Research	14
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	16
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	18
Figure 5. Asia Pacific Enteral Nutrition Market, 2019-2030, $ mn	21
Figure 6. Impact of COVID-19 on Business	24
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Enteral Nutrition Market	26
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Enteral Nutrition Market	29
Figure 9. Investment Opportunity Analysis	33
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Enteral Nutrition Market	36
Figure 11. Breakdown of Asia Pacific Enteral Nutrition Market by Nutrient, 2019-2030, % of Revenue	41
Figure 12. Asia Pacific Addressable Market Cap in 2021-2030 by Nutrient, Value ($ mn) and Share (%)	41
Figure 13. Asia Pacific Enteral Nutrition Market by Nutrient: Protein Based Nutrition, 2019-2030, $ mn	42
Figure 14. Asia Pacific Enteral Nutrition Market by Protein Based Nutrition: Standard Protein Diet, 2019-2030, $ mn	44
Figure 15. Asia Pacific Enteral Nutrition Market by Protein Based Nutrition: High Protein Supplement, 2019-2030, $ mn	45
Figure 16. Asia Pacific Enteral Nutrition Market by Protein Based Nutrition: Protein for Diabetic Patients, 2019-2030, $ mn	46
Figure 17. Asia Pacific Enteral Nutrition Market by Protein Based Nutrition: Other Protein-based Nutitions, 2019-2030, $ mn	47
Figure 18. Asia Pacific Enteral Nutrition Market by Nutrient: Carbohydrates Based Nutrition, 2019-2030, $ mn	48
Figure 19. Asia Pacific Enteral Nutrition Market by Nutrient: Fat Based Nutrition, 2019-2030, $ mn	49
Figure 20. Asia Pacific Enteral Nutrition Market by Nutrient: Vitamin Based Nutrition, 2019-2030, $ mn	50
Figure 21. Asia Pacific Enteral Nutrition Market by Nutrient: Other Nutrition Types, 2019-2030, $ mn	51
Figure 22. Breakdown of Asia Pacific Enteral Nutrition Market by Application, 2019-2030, % of Sales Revenue	53
Figure 23. Asia Pacific Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%)	53
Figure 24. Asia Pacific Enteral Nutrition Market by Application: Critical Care, 2019-2030, $ mn	54
Figure 25. Asia Pacific Enteral Nutrition Market by Application: Diabetes, 2019-2030, $ mn	55
Figure 26. Asia Pacific Enteral Nutrition Market by Application: Neurology, 2019-2030, $ mn	56
Figure 27. Asia Pacific Enteral Nutrition Market by Application: Oncology, 2019-2030, $ mn	57
Figure 28. Asia Pacific Enteral Nutrition Market by Application: Other Applications, 2019-2030, $ mn	58
Figure 29. Breakdown of Asia Pacific Enteral Nutrition Market by Category, 2019-2030, % of Sales Revenue	60
Figure 30. Asia Pacific Addressable Market Cap in 2021-2030 by Category, Value ($ mn) and Share (%)	60
Figure 31. Asia Pacific Enteral Nutrition Market by Category: Enteral Nutrition for Chronic Illness, 2019-2030, $ mn	61
Figure 32. Asia Pacific Enteral Nutrition Market by Category: Enteral Nutrition with Standard Formula, 2019-2030, $ mn	62
Figure 33. Breakdown of Asia Pacific Enteral Nutrition Market by Product Form, 2019-2030, % of Revenue	64
Figure 34. Asia Pacific Addressable Market Cap in 2021-2030 by Product Form, Value ($ mn) and Share (%)	64
Figure 35. Asia Pacific Enteral Nutrition Market by Product Form: Liquid Enteral Nutrition, 2019-2030, $ mn	65
Figure 36. Asia Pacific Enteral Nutrition Market by Product Form: Powder Enteral Nutrition, 2019-2030, $ mn	66
Figure 37. Breakdown of Asia Pacific Enteral Nutrition Market by End User, 2019-2030, % of Revenue	68
Figure 38. Asia Pacific Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)	68
Figure 39. Asia Pacific Enteral Nutrition Market by End User: Pediatric, 2019-2030, $ mn	69
Figure 40. Asia Pacific Enteral Nutrition Market by End User: Adults, 2019-2030, $ mn	70
Figure 41. Asia Pacific Enteral Nutrition Market by End User: Geriatric, 2019-2030, $ mn	71
Figure 42. Breakdown of Asia Pacific Enteral Nutrition Market by Distribution Channel, 2019-2030, % of Revenue	72
Figure 43. Asia Pacific Addressable Market Cap in 2021-2030 by Distribution Channel, Value ($ mn) and Share (%)	73
Figure 44. Asia Pacific Enteral Nutrition Market by Distribution Channel: Distribution by Hospitals, 2019-2030, $ mn	74
Figure 45. Asia Pacific Enteral Nutrition Market by Distribution Channel: Distribution by Retail Pharmacies, 2019-2030, $ mn	75
Figure 46. Asia Pacific Enteral Nutrition Market by Distribution Channel: Distribution by Online Pharmacies, 2019-2030, $ mn	76
Figure 47. Breakdown of APAC Enteral Nutrition Market by Country, 2019 and 2030, % of Revenue	78
Figure 48. Contribution to APAC 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	79
Figure 49.  Enteral Nutrition Market in Japan, 2019-2030, $ mn	81
Figure 50.  Enteral Nutrition Market in China, 2019-2030, $ mn	84
Figure 51.  Enteral Nutrition Market in Australia, 2019-2030, $ mn	87
Figure 52.  Enteral Nutrition Market in India, 2019-2030, $ mn	89
Figure 53.  Enteral Nutrition Market in South Korea, 2019-2030, $ mn	92
Figure 54.  Enteral Nutrition Market in Rest of APAC, 2019-2030, $ mn	95
Figure 55. Growth Stage of Asia Pacific Enteral Nutrition Industry over the Forecast Period	97
Figure 56. Nestlé S.A.: Revenue by Region, 2018	126
Key Players (this may not be a complete list and extra companies can be added upon request): 
Abbott Laboratories
B. Braun Melsungen AG
Baxter International, Inc.
Danone S.A.
Fresenius Kabi AG
Asia Pacific Health Products, Inc.
Hormel Foods Corporation
Meiji Holdings Co., Ltd.
Nestle S.A.
Reckitt Benckiser (Mead Johnson & Company LLC)
Victus, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)